Posted Jun. 28, 2011 at 12:17 p.m.
Biohazard symbol
Image 1 of 2 · Next Image…
Chimerix fought the award of a sole-source contract for a potential smallpox treatment to another firm and convinces the government agency involved to overturn it. Now, Chimerix can compete for a lucrative deal, CEO says.Copyright 2013 WRAL Tech Wire. All rights reserved.
Durham biotech firm wins round in $2B contract battle
Post a comment
Print this blog postE-mail blog post
Share
Biohazard symbol
Image 1 of 2 · Next Image…
Chimerix fought the award of a sole-source contract for a potential smallpox treatment to another firm and convinces the government agency involved to overturn it. Now, Chimerix can compete for a lucrative deal, CEO says.Copyright 2013 WRAL Tech Wire. All rights reserved.
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
The Skinny
WRAL Local Tech Wire Publisher and Editor Rick Smith dishes out tidbits from the local technology sector. Read more articles…
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Raleigh-based PRA International eyes public offering- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows
- Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
- Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
- ChannelAdvisor seeks $80M, sets share target price for IPO
- IT job openings 28% below 2012 numbers, report shows